These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 102100)

  • 1. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma globulin inhibition of fibrin clot formation.
    Davey FR; Gordon GB; Boral LI; Gottlieb AJ
    Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased thrombin time in a patient with multiple myeloma].
    Bohler A; Redondo M; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED; Shainoff JR; Graham RC; Ratnoff OD
    J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a fibrin formation abnormality in a case of multiple myeloma.
    Soria J; Soria C; Samama M; Fine JM; Bousser J
    Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological classification of 31 multiple myeloma patients.
    Qiu WX; Huang NH; Wu GH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):79-83. PubMed ID: 2123037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin polymerization defect in HIV-infected patients--evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times.
    Toulon P; Frere E; Bachmeyer C; Candia N; Blanche P; Sereni D; Sicard D
    Thromb Haemost; 1995 Mar; 73(3):349-55. PubMed ID: 7667815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin time.
    Van Cott EM; Smith EY; Galanakis DK
    Am J Clin Pathol; 2002 Aug; 118(2):263-8. PubMed ID: 12162688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies.
    Fine JM; Lambin P
    Biomedicine; 1975 Oct; 23(8):323-7. PubMed ID: 821548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired dysfibrinogenemia secondary to multiple myeloma.
    Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
    Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of multiple myeloma with double M-protein peaks for IgG-kappa and IgA-kappa].
    Tadao F; Hayashi M; Ichikawa K; Hirasawa Y; Ohtani H; Saito M; Hatimura K; Oshikawa T; Takayama M; Mori N
    Rinsho Ketsueki; 1984 Oct; 25(10):1646-52. PubMed ID: 6441031
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of impaired fibrin polymerization in patients with the nephrotic syndrome.
    Mysliwiec M; Ralston A; Ackrill P; Poller L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):73-8. PubMed ID: 1695187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diverse hemostatic abnormalities in a patient with biclonal multiple myeloma].
    Komiya I; Ito T; Ogata K; Yamada T; Dan KZ; Kuriya S; Nomura T
    Rinsho Ketsueki; 1990 Jan; 31(1):62-5. PubMed ID: 2107347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of IgG myeloma with tetrameric Bence Jones proteinemia and abnormal fibrin polymerization (author's transl)].
    Inoue S; Nagata H; Yozawa H; Terai T; Hasegawa H; Murao M
    Rinsho Ketsueki; 1980 Feb; 21(2):200-7. PubMed ID: 6774128
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
    Papadea C; Reimer CB; Check IJ
    Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelomatous G-kappa immunoglobulin with antistreptolysin O activity].
    Tobelem G; Krulik M; Mougeot-Martin M; Audebert AA; Debray J
    Nouv Presse Med; 1976 Nov; 5(38):2515-8. PubMed ID: 824622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired ristocetin aggregation in myeloma due to binding of the aggregating agent by monoclonal protein--presentation of a case.
    László E; Péterfy M; Puskás E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):852-6. PubMed ID: 2453415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.